A PhD from the St. Jude Children's Research Hospital Graduate School of Biomedical Sciences is like no other. With leading-edge science, unparalleled resources, and unique clinical experience, our graduate program is designed to create scientific leaders who will discover the next generation of cures.
The innovative curriculum is for independent students who thrive in an interactive, challenging and creative research environment. Doctoral research can be pursued in diverse areas with top basic and translational research faculty. Beyond our global leadership in pediatric oncology, St. Jude has superb programs in infectious diseases, genetic and blood disorders, drug discovery and international medicine.
Clinical care experience is a fundamental component of the program. Students interact extensively with medical experts and follow St. Jude patients from the beginning of their first year.
Throughout training, students are supported by generous benefits, extraordinary core facilities, and a collaborative, close-knit environment — all in the heart of the vibrant, musical city of Memphis.
Admissions
The Graduate School welcomes talented applicants from diverse scientific backgrounds. Learn more about eligibility, important dates and how to apply.
Benefits
The St. Jude Graduate School offers PhD students a highly competitive stipend, excellent benefits and exceptional support for their research.
Our Faculty
The St. Jude Graduate School faculty includes leading scientists and clinical investigators from diverse research areas.
Grad School News & Features
-
St. Jude researchers create an analytic tool that opens a new frontier of cancer discovery
St. Jude Children’s Research Hospital scientists have developed software to identify cancer-causing mutations lurking in vast regions of the human genome
-
Streamlined and scalable CHANGE-Seq method improves understanding of genome editors
New research tool helps define unintended off-target effects of CRISPR genome editing, making the process safer and more precise.
-
Cytokine implicated in HLH treatment resistance
Research sheds light on cytokine storm syndromes and how ruxolitinib may benefit patients with hemophagocytic lymphohistiocytosis.
The St. Jude Children's Research Hospital Graduate School of Biomedical Sciences is authorized for operation as a postsecondary educational institution by the Tennessee Higher Education Commission. In order to view detailed job placement and graduation information on the programs offered by the St. Jude Children's Research Hospital Graduate School of Biomedical Sciences, please visit http://www.tn.gov/thec/bureaus/student-aid-and-compliance/postsecondary-state-authorization/authorized-institutions-and-data.html.